Initiating oncogenic event determines gene-expression patterns of human breast cancer models

Kartiki V. Desai, Nianqing Xiao, Weili Wang, +10

Proceedings of the National Academy of Sciences

Circular RNAs are differentially expressed in prostate cancer and are potentially associated with resistance to enzalutamide

John Greene, Anne‐Marie Baird, Órla Casey, +7

Scientific Reports

Secreted factors from metastatic prostate cancer cells stimulate mesenchymal stem cell transition to a pro‐tumourigenic ‘activated’ state that enhances prostate cancer cell migration

Sarah Ridge, Dibyangana D. Bhattacharyya, Eoin Dervan, +8

International Journal of Cancer

Stem Cell MigrationCancer BiologyTumor BiologyStem Cell MobilizationCancer Cell Biology +17

Circulating Tumour Cell Numbers Correlate with Platelet Count and Circulating Lymphocyte Subsets in Men with Advanced Prostate Cancer: Data from the ExPeCT Clinical Trial (CTRIAL-IE 15-21)

Brian Hayes, Lauren Brady, Gráinne Sheill, +26

Cancers

Effectiveness of Reminder Systems on Appointment Adherence Rates

Susan Maxwell, Rose Maljanian, Sheryl Horowitz, +3

Journal of Health Care for the Poor and Underserved

NursingFamily MedicinePrimary CarePreventive MedicineHealth Policy +12

Platelet cloaking of circulating tumour cells in patients with metastatic prostate cancer: Results from ExPeCT, a randomised controlled trial

Lauren Brady, Brian Hayes, Gráinne Sheill, +24

PLoS ONE

Differential CircRNA Expression Signatures May Serve as Potential Novel Biomarkers in Prostate Cancer

John Greene, Anne‐Marie Baird, Marvin Lim, +7

Frontiers in Cell and Developmental Biology

Linking Circulating Serum Proteins with Clinical Outcomes in Esophageal Adenocarcinoma—An Emerging Role for Chemokines

Noel E. Donlon, Andrew Sheppard, Maria Davern, +16

Cancers

Tumor BiologyPrognostic BiomarkersCancer ImmunosurveillanceEsophageal CancerGastrointestinal Oncology +13

Prostate cancer-derived holoclones: a novel and effective model for evaluating cancer stemness

Louise Flynn, Martin P. Barr, Anne‐Marie Baird, +10

Scientific Reports

Radium-223 in combination with enzalutamide in metastatic castration-resistant prostate cancer: a multi-centre, phase II open-label study

Ray McDermott, John Greene, John McCaffrey, +11

Therapeutic Advances in Medical Oncology